1. Home
  2. ALZN vs EEIQ Comparison

ALZN vs EEIQ Comparison

Compare ALZN & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$2.14

Market Cap

9.0M

Sector

Health Care

ML Signal

HOLD

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$0.34

Market Cap

8.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALZN
EEIQ
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
9.0M
8.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ALZN
EEIQ
Price
$2.14
$0.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$42.00
N/A
AVG Volume (30 Days)
98.5K
59.2K
Earning Date
12-09-2025
01-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$9,358,301.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
44.99
52 Week Low
$1.88
$0.23
52 Week High
$12.06
$1.74

Technical Indicators

Market Signals
Indicator
ALZN
EEIQ
Relative Strength Index (RSI) 48.42 37.32
Support Level $2.09 $0.33
Resistance Level $2.27 $0.35
Average True Range (ATR) 0.14 0.02
MACD 0.01 0.01
Stochastic Oscillator 68.09 38.62

Price Performance

Historical Comparison
ALZN
EEIQ

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

Share on Social Networks: